Christoffer Rosenblad
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Christoffer Rosenblad is currently Chief Executive Officer at Xvivo Perfusion AB since 2022, Director at Bentley Endovascular Group AB, and Independent Director at Sedana Medical AB since 2020.
Formerly, Mr. Rosenblad worked as Controller at Ciba Vision Nordic AB. Education includes a graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,17% | 29/07/2025 | 53.523 ( 0,17% ) | 2 M $ | 31/05/2026 |
SEDANA MEDICAL AB 0,02% | 31/12/2024 | 20.000 ( 0,02% ) | 20 383 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| XVIVO PERFUSION AB | Amministratore Delegato | 27/09/2022 |
| SEDANA MEDICAL AB | Direttore/Membro del Consiglio | 19/05/2020 |
| Società | Posizione | Fine |
|---|---|---|
Ciba Vision Nordic AB | Comptroller/Controller/Auditor | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba Vision Nordic AB | |
Xvivo Perfusion AB
Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale